Human Anti-APLNR Recombinant Antibody (TAB-0938CLV) (CAT#: TAB-0938CLV)
This product is a recombinant human antibody that recognizes APLNR. The antibody was purified by affinity chromatography.
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
Figure 1 Human Anti-APLNR Recombinant Antibody (TAB-0938CLV) in SDS-PAGE
SDS-PAGE analysis of TAB-0938CLV in β-mercaptoethanol-reduced (Lane 1, 1.5 μg) and non-reduced (Lane 2, 1.5 μg) conditions. Gel stained for 30 minutes with Coomassie Blue. As a result of different reduced proteins (heavy chain and light chain) migrate as about 25 kDa.
Figure 2 Human Anti-APLNR Recombinant Antibody (TAB-0938CLV) in SEC-HPLC
The purity of TAB-0938CLV was greater than 95% as determined by SEC-HPLC.
Column: 3 µm, 7.8 x 300 nm
Mobile phase: 150 mM Sodium Phosphate Buffer, pH 7.0
Detection: UV 280 nm
Injection: 10 µl
Figure 3 Human Anti-APLNR Recombinant Antibody (TAB-0938CLV) in FACS
Flow cytometry analysis of THP-1 cell with purified antibody TAB-0938CLV (Green). Cells (1x10^6) were incubated with TAB-0938CLV (Unconjugated, 50 μg/mL) for 30 min at 4°C. The FITC-goat anti-human IgG antibody was used as secondary antibody and incubated at a concentration of 20 μg/mL for 30 min at 4°C. The negative control group (Red) was only incubated with the secondary antibody.
Specifications
- Host Species
- Human
- Type
- Human IgG4
- Specificity
- Human APLNR
- Species Reactivity
- Human
- Applications
- ELISA
- Related Disease
- Cardiovascular diseases, Angiogenesis diseases, Metabolic diseases, Fibrotic diseases
Product Property
- Purity
- >95% as determined by SDS-PAGE
- Buffer
- PBS
- Preservative
- No preservatives
- Storage
- Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Target
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "APLNR"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-0929CLV | Mouse Anti-APLNR Recombinant Antibody (TAB-0929CLV) | ELISA | Mouse IgG1 |
TAB-0930CLV | Human Anti-APLNR Recombinant Antibody (TAB-0930CLV) | ELISA | Chimeric (mouse/human) IgG |
TAB-0929CLV-F(E) | Mouse Anti-APLNR Recombinant Antibody (TAB-0929CLV-F(E)); Fab Fragment | ELISA | Mouse Fab |
TAB-0930CLV-F(E) | Human Anti-APLNR Recombinant Antibody; Fab Fragment (TAB-0930CLV-F(E)) | ELISA | Chimeric (mouse/human) Fab |
TAB-0931CLV-F(E) | Human Anti-APLNR Recombinant Antibody; Fab Fragment (TAB-0931CLV-F(E)) | ELISA | Chimeric (mouse/human) Fab |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for TAB-0938CLV. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: Inhib, Cyt
Application: ELISA, FC, IP, FuncS, IF, Neut, WB
Application: ELISA, SPR, Inhib, FuncS
Application: ELISA
Application: FC, IHC-Fr, IP, ELISA, Block
Application: ELISA, IHC, FC, IP, IF, FuncS
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.